The Mayo Clinic notes that age, hormonal changes, and muscle loss can all contribute to weight gain and metabolic shifts around menopause
#Omeprazole #ProtonPumpInhibitors #PPI #RationalPrescribing #PatientSafety #MedicationSafety ##HealthcareProfessionals To view or add a comment, sign in After a pause- Metabolic bytes #9- GLP-1RAs are incretin mimetics used primarily for the treatment of Type 2 diabetes and obesity
Now, FDA policy has changed, so patients need clear facts before they make health, access, and cost decisions
The modulatory influence of several natural compounds on miRNA functioning in cancers is demonstrated in numerous investigations
A commentary in the Journal of Medical Internet Research identified a clinical support gap in telehealth-based GLP-1 care: platforms are effective at writing the initial prescription but often lack robust infrastructure for ongoing monitoring, dietary counseling, and dose adjustment [5]